Virgin Galactic stock forecast (NYSE:SPCE) – will the stock hit $50 again in 2021?

Virgin Galactic Holdings Inc (NYSE: SPCE)  stock has been gaining serious traction on Wallstreet, now up 113% this month. The stock is gaining momentum after the completion of the first human spaceflight from the Spaceport America, New Mexico. The milestone marks the success of the companies third test spaceflight which will provide valuable data for the company to review and plan its next milestone.…

CCIV closes in on merger with Lucid Motors – here’s why investors are excited

The SPAC company Churchill Capital Corp IV (NYSE: CCIV) gained traction on Wallstreet after announcing their intentions to merge with EV company Lucid Motors. Lucid Motors has captivated investors after noting their ambitions to take on EV giant Tesla. Interestingly, Lucid Motors CEO Peter Rawlinson had spent time as an engineering executive at Tesla prior to launching Lucid Motors.…

Ocugen stock (NASDAQ:OCGN) gains momentum ahead of EUA submission

Ocugen Inc (NASDAQ: OCGN) is a US based bio-pharma which has focused on developing a cure for blindness disease. However, the company has since shifted its efforts to develop a COVID-19 vaccine with partner Bharat Biotech. Ocugen’s CEO Shankar Musunuri has made it clear the company strategises to disrupt the current COVID-19 vaccine market with Covaxin.…

Novavax stock forecast (NASDAQ: NVAX) – are investors buying now?

Novavax, Inc.(NASDAQ: NVAX) has seen an incredible year in stock price growth, increasing 307% over the past 12 months. The companies COVID-19 vaccine saw the market rally behind NVAX, posting a 52 week high in February of $331.68. The company announced yesterday that their COVID-19 vaccine NVX-CoV2373 demonstrated 100% protection against moderate and severe disease and a 90.4% efficacy overall in the Phase 3 trial.…

Vaxart stock (NASDAQ: VXRT) surges after analyst sees 105% upside

Vaxart Inc (NASDAQ: VXRT) stock has seen a recent spike in investor confidence, gaining 23.81% over the past week. Vaxart has developed an oral vaccine for COVID-19 which has vastly differentiated itself from the competition. A recent study by Quadrant Strategies has shown that one third of people refusing to be vaccinated for COVID-19, would take an oral vaccine as an alternative to an injection.…